Regional action needed to halt antimalarial drug resistance in Africa.
作者信息
Martinez-Vega Rosario, Ishengoma Deus S, Gosling Roly, Rosenthal Philip J, Dondorp Arjen, Barnes Karen I, Nsanzabana Christian, Djimde Abdoulaye A, Ochola-Oyier Lynette I, Tibenderana James, Chimumbwa John, Golassa Lemu, Kapologwe Ntuli A, Mbacham Wilfred F, Kamya Moses R, Fidock David A, Komatsu Ryuichi, von Seidlein Lorenz, Dhorda Mehul
机构信息
Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
National Institute for Medical Research, Dar es Salaam, Tanzania; Department of Biochemistry, Kampala International University in Tanzania, Dar es Salaam, Tanzania.
出版信息
Lancet. 2025 Jan 4;405(10472):7-10. doi: 10.1016/S0140-6736(24)02706-5. Epub 2024 Dec 12.
Abstract
摘要
相似文献
1
Regional action needed to halt antimalarial drug resistance in Africa.非洲需要采取区域行动来遏制抗疟药物耐药性。
Lancet. 2025 Jan 4;405(10472):7-10. doi: 10.1016/S0140-6736(24)02706-5. Epub 2024 Dec 12.
2
Azithromycin for treating uncomplicated malaria.阿奇霉素用于治疗非复杂性疟疾。
Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD006688. doi: 10.1002/14651858.CD006688.pub2.
3
Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.非洲的抗叶酸药物耐药性：对非洲恶性疟原虫寄生虫种群中报道的二氢叶酸还原酶（dhfr）和二氢蝶酸合成酶（dhps）突变基因型频率的荟萃分析。
Malar J. 2010 Aug 30;9:247. doi: 10.1186/1475-2875-9-247.
4
Recent advances in the synthesis and antimalarial activity of 1,2,4-trioxanes.1,2,4-三噁烷类化合物的合成及抗疟活性的最新进展。
Bioorg Chem. 2024 Feb;143:107043. doi: 10.1016/j.bioorg.2023.107043. Epub 2023 Dec 19.
5
Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa.非洲青蒿素及联合用药耐药性持续传播的选择风险和时间线。
medRxiv. 2024 Aug 28:2024.08.28.24312699. doi: 10.1101/2024.08.28.24312699.
6
The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials.间日疟调查员：用于间日疟临床试验的在线地图数据库。
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):181-190. doi: 10.1016/j.ijpddr.2017.03.003. Epub 2017 Mar 24.
7
Antimalarial drug prescriptions and clinical outcomes of febrile children in Arba Minch City, South Ethiopia.埃塞俄比亚南部阿尔巴明奇市发热儿童的抗疟药处方及临床结局
Malar J. 2025 Jun 20;24(1):197. doi: 10.1186/s12936-025-05449-9.
8
Dengue diagnosis and impact on clinical management: A literature review.登革热诊断及其对临床管理的影响：文献综述
PLoS Negl Trop Dis. 2025 Jun 30;19(6):e0013196. doi: 10.1371/journal.pntd.0013196. eCollection 2025 Jun.
9
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005.基因分型在抗疟临床试验中的应用：对1995年至2005年已发表研究的系统评价
Malar J. 2006 Dec 14;5:122. doi: 10.1186/1475-2875-5-122.
10
Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action.加强非洲的疫苗安全系统、研究与区域合作：行动呼吁。
Vaccines (Basel). 2025 Jun 19;13(6):661. doi: 10.3390/vaccines13060661.
引用本文的文献
1
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.2019 - 2024年期间乌干达恶性疟原虫对抗疟药物敏感性的变化
Nat Commun. 2025 Aug 9;16(1):7353. doi: 10.1038/s41467-025-62810-x.
2
Malaria: past, present, and future.疟疾：过去、现在与未来。
Signal Transduct Target Ther. 2025 Jun 17;10(1):188. doi: 10.1038/s41392-025-02246-3.
3
The hematin-dihydroartemisinin adduct mobilizes a potent mechanism to suppress β-hematin crystallization.血红素-双氢青蒿素加合物启动了一种有效的机制来抑制β-血红素结晶。
J Biol Chem. 2025 Jul;301(7):110310. doi: 10.1016/j.jbc.2025.110310. Epub 2025 May 29.
本文引用的文献
1
Resistant malaria parasites gaining momentum in Africa.抗药性疟原虫在非洲呈蔓延之势。
Lancet Infect Dis. 2024 Nov;24(11):1181-1182. doi: 10.1016/S1473-3099(24)00413-4. Epub 2024 Aug 16.
2
Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug.非洲恶性疟原虫对青蒿素联合疗法产生耐药性令人担忧：辅助药物的关键作用
Lancet Infect Dis. 2024 Sep;24(9):e540-e541. doi: 10.1016/S1473-3099(24)00427-4. Epub 2024 Jul 22.
3
Artemisinin-resistant malaria in Africa demands urgent action.非洲出现的青蒿素耐药性疟疾急需采取行动。
Science. 2024 Jul 19;385(6706):252-254. doi: 10.1126/science.adp5137. Epub 2024 Jul 18.
4
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites.需要采取紧急行动来应对非洲疟原虫对青蒿素的部分耐药性。
Nat Med. 2024 Jul;30(7):1807-1808. doi: 10.1038/d41591-024-00028-y.
5
The emergence of artemisinin partial resistance in Africa: how do we respond?非洲青蒿素部分抗性的出现：我们如何应对？
Lancet Infect Dis. 2024 Sep;24(9):e591-e600. doi: 10.1016/S1473-3099(24)00141-5. Epub 2024 Mar 26.
6
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.非洲青蒿素部分耐药疟原虫的出现、传播动态和机制。
Nat Rev Microbiol. 2024 Jun;22(6):373-384. doi: 10.1038/s41579-024-01008-2. Epub 2024 Feb 6.
7
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa.证据表明，斯蒂芬斯按蚊在非洲传播耐药疟疾方面发挥了作用。
Nat Med. 2023 Dec;29(12):3203-3211. doi: 10.1038/s41591-023-02641-9. Epub 2023 Oct 26.
8
Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies.2016 - 2020年东地中海区域HANMAT - PIAM_net国家疟疾流行国家的抗疟药物疗效与耐药性：临床与遗传学研究
Trop Med Int Health. 2023 Oct;28(10):817-829. doi: 10.1111/tmi.13929. Epub 2023 Sep 13.
9
Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.乌干达疟原虫对青蒿素类药物部分耐药性的演变。
N Engl J Med. 2023 Aug 24;389(8):722-732. doi: 10.1056/NEJMoa2211803.
10
Reactive surveillance and response strategies for malaria elimination in Myanmar: a literature review.缅甸消除疟疾的反应性监测和应对策略：文献综述。
Malar J. 2023 Apr 27;22(1):140. doi: 10.1186/s12936-023-04567-6.
Zotero 插件